tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Sean Mccutcheon, 18 are a BUY (100%).
Analyst Sean Mccutcheon, currently employed at RAYMOND JAMES, carries an average stock price target met ratio of 25% that have a potential upside of 9.29% achieved within 48 days.
Sean Mccutcheon’s has documented 36 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on XNCR, Xencor at 31-Aug-2026.
Analyst best performing recommendations are on RVMD (REVOLUTION MEDICINES).
The best stock recommendation documented was for CYTK (CYTOKINETICS) at 12/28/2023. The price target of $92 was fulfilled within 8 days with a profit of $8.76 (10.52%) receiving and performance score of 13.15.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 23-May-2022
9 days ago
(23-Sep-2026)
0/5 (0%)
$19.07 (386.82%)
Buy Since 03-Dec-2025
$4
$2.87 (253.98%)
$10
9 days ago
(23-Sep-2026)
0/4 (0%)
$2.83 (241.88%)
Buy Since 16-Dec-2021
$1
$-0.13 (-11.50%)
9 days ago
(23-Sep-2026)
0/2 (0%)
$-0.17 (-14.53%)
Buy Since 24-Feb-2025
$4
$2.87 (253.98%)
$12
9 days ago
(23-Sep-2026)
0/5 (0%)
$2.83 (241.88%)
Buy Since 19-Feb-2025
$6
$4.87 (430.97%)
$12
1 months 25 days ago
(07-Aug-2026)
0/5 (0%)
$3.85 (179.07%)
Which stock is Sean Mccutcheon most bullish on?
What Year was the first public recommendation made by Sean Mccutcheon?
